Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000664819 | SCV000788836 | uncertain significance | Usher syndrome type 1F | 2017-01-06 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001241412 | SCV001414426 | uncertain significance | not provided | 2024-10-25 | criteria provided, single submitter | clinical testing | This sequence change replaces arginine, which is basic and polar, with histidine, which is basic and polar, at codon 1405 of the PCDH15 protein (p.Arg1405His). This variant is present in population databases (rs143538460, gnomAD 0.008%). This missense change has been observed in individual(s) with non-syndromic deafness (PMID: 26969326). This variant is also known as NM_001142763:c.4229G>A (p.Arg1410His). ClinVar contains an entry for this variant (Variation ID: 550153). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed for this missense variant. However, the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on PCDH15 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Broad Center for Mendelian Genomics, |
RCV000664819 | SCV003761038 | uncertain significance | Usher syndrome type 1F | 2023-01-24 | criteria provided, single submitter | curation | The p.Arg1405His variant in PCDH15 has been reported in 1 individual, in the compound heterozygous state, with Usher syndrome type 1F (PMID: 26969326) and has been identified in 0.008% (2/24962) of African/African American chromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org; dbSNP ID: rs143538460). This variant has also been reported in ClinVar (Variation ID#: 550153) and has been interpreted as a variant of uncertain significance by Counsyl, Invitae, and Natera, Inc.. Although this variant has been seen in the general population in a heterozygous state, its frequency is low enough to be consistent with a recessive carrier frequency. Computational prediction tools and conservation analyses do not provide strong support for or against an impact to the protein. In summary, the clinical significance of the p.Arg1405His variant is uncertain. ACMG/AMP Criteria applied: PM2_supporting (Richards 2015). |
Gene |
RCV001241412 | SCV003803381 | uncertain significance | not provided | 2023-04-25 | criteria provided, single submitter | clinical testing | Observed with the PCDH15 N221S variant in a patient with hearing loss in published literature; it is not known whether the variants occurred on the same (in cis) or on different (in trans) chromosomes (Sloan-Heggen et al., 2016; described as R1410H using alternate nomenclature); In silico analysis supports that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 26969326) |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV004525998 | SCV005040067 | uncertain significance | not specified | 2024-03-07 | criteria provided, single submitter | clinical testing | Variant summary: PCDH15 c.4214G>A (p.Arg1405His) results in a non-conservative amino acid change in the encoded protein sequence. Four of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 2.8e-05 in 249056 control chromosomes. The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. c.4214G>A has been reported in the literature as NM_001142763.2:c.4229G>A (p.Arg1410His), in a non-informative genotype in at-least one individual with a clinical diagnosis of autosomal recessive non-syndromic hearing loss (second allele classification and/or phase not clearly specified) (example, Sloan-Heggen_2016). These report(s) do not provide unequivocal conclusions about association of the variant with Usher Syndrome Type 1F. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publication have been ascertained in the context of this evaluation (PMID: 26969326). ClinVar contains an entry for this variant (Variation ID: 550153). Based on the evidence outlined above, the variant was classified as uncertain significance. |
Natera, |
RCV000664819 | SCV002092344 | uncertain significance | Usher syndrome type 1F | 2020-02-14 | no assertion criteria provided | clinical testing |